Table 3 Mortality rate ratios and 95% confidence intervals for death from cancer associated with various characterstics in persons diagnosed with cancer of the lung, colon, rectum, breast, prostate, or non-Hodgkin's lymphoma (NHL)^a in Denmark 1982-2003

Male gender ^b

1.27 (1.24-1.29)

Age group (years) ^c

   70-79

1.29 (1.26-1.31)

   80-89

1.61 (1.57-1.65)

   90-99

2.32 (2.15-2.50)

Age difference ^d

0.98 (0.98-0.98)

Calendar period ^e

   1987-1991

0. 97 (0.95-1.00)

   1992-1996

0.87 (0.85-0.89)

   1997-2001

0.65 (0.63-0.66)

   2002-2003

0.49 (0.47-0.51)

Comorbidity level ^f

   Moderate

1.22 (1.19-1.24)

   High

1.43 (1.37-1.49)

Stage ^g

   Regional

2.28 (2.22-2.33)

   Distant

3.35 (3.26-3.44)

   Unknown/missing

1.24 (1.21-1.28)

Treatment of index cancer

   No/symptomatic

0.93 (0.89-0.96)

   Chemotherapy

1.01 (0.98-1.05)

   Radiation

1.19 (1.16-1.23)

   Operation

0.45 (0.44-0.47)

   Hormone therapy

0.57 (0.55-0.59)

   Missing/other

0.59 (0.56-0.62)

Any autoimmune disease ^h

1.07 (1.02-1.11)